There is a very profound decrease and/or a reduced function of FKBP52 that we have described in pathological circumstances: in Alzheimer’s disease, FTDP17 (9), and other tauopathies. Here, FKBP4 is linked to early-onset autosomal dominant Alzheimer disease.